This website uses cookies to ensure you have the best experience. Learn more

Metabical Essay

2488 words - 10 pages


Situational Analysis and SWOT

Situational Analysis Item | Issues-Facts | Implications to Situation | SWOT |
Organization Structure | | | |
1 | Barbara Printup has over 20 years of experience marketing prescription drugs | Experience helps in the marketing and launch strategy for s new product to market | S |
Leadership | | | |
1 | $25B in sales in 2007 | Brand recognition is key | S |
2 | Clinical trials performed to show majority of individuals reached weight-loss goals by week 12 and minimal weight loss after that | By generating data through clinical trials, FDA clearance is a route which is an opportunity over its OTC and supplement competitors | S |
...view middle of the document...

Will be challenging to pull customers away. | T |
3 | Competitors include Alii, OTC drugs/supplements, weight watchers, Jenny Craig and gym memberships | Competitors with a large following and brand recognition will be challenging to pull customers away. | T |

SWOT Profile

| | Strengths |   | Weaknesses |
| | Barbara Printup has over 20 years of experience marketing prescription drugs | | 10 years of testing and $400 million in R&D costs |
| | $25B in sales in 2007 | | Negative side effects occur when users consume high levels of fat and calories |
| | Clincal data showing efficacy | | New to dietary drug world |
| | Researchers at CSP combined an appetite suppressant (calosera) with a fat-blocking agent (meditonan) to for Metabical | |   |
| |   | |   |
| | | | |
Opportunities | |   | |   |
No prescription-drug options avaliable specifically for the overweight segment (BMI 25-30) | | By combining an appetite suppressant (calosera) with a fat-blocking agent (meditonan), the segment of overweight people can now be targeted | | By efectively penetrating the large $3.74B market, overcoming the time and money spent in R&D should not be a problem |
$3.74 billion market for weight-control products in the US | | The support program can help get overweight/obesity away from being one of the leading causes in preventable death by explaining how Metibical works | | Negative side effects occur when users consume high levels of fat and calories can be overcome by using th support program to educate consumers on how to effictively use the product |
By 2008, over 65% of the 230 million adults in the US were considered overwight, obese, or severely obese | | Invest some of the $25B in sales in order to penetrate the $3.74B market' | |   |
Being overweight is "The second leading cause of preventable death in the US" | |   | |   |
Support program planned to complement pill | |   | |   |

Threats | | | |   |
Most health insurace carriers are not expected to reimburse patients for Metabical costs | | Using clinical data showing efficacy can be used to show how much better Metabical is compared to the OTC products and to persuade insurance providers to cover the drug | | Even though there are negative side effects occur when useres consume high levels of fat and calories, by showing the overall good of the product, competitors will have no chance to compete |
Prescription weight-loss drugs already approved for use in both obese and severely obese individuals | | By combining an appetite suppressant (calosera) with a fat-blocking agent (meditonan) to form Metabical, the combination can be shown to be much moreeffective than the OTC competitiors and the diet supplements on the market | | By using the resources and time in R&D to come up with Metabical, the research can be used to show health insurance providers that Metibical should be covered and to show how much better...

Other Papers Like Metabical

Metabical Case Essay

582 words - 3 pages Reinald Nathaniel 29115153 – Syndicate 1 Metabical Case According to the data and our calculation, there are two methods that could be used to be consider in Metabical’s pricing strategy. First we would narrow the population into a niche market by filtering the numbers. It is done by taking the number of people who tries to lose weight, then the next filter that we put is: to sort out by the number of people who are comfortable in using pills

Metabical-Case Study

4548 words - 19 pages rP os t 4183 APRIL 14, 2010 JOHN A. QUELCH HEATHER BECKHAM op yo Metabical: Pricing, Packaging, and Demand Forecasting for a New Weight-Loss Drug In April 2008, after 10 years of testing and $400 million in research and development costs, Cambridge Sciences Pharmaceuticals’ (CSP) newest prescription drug, Metabical (pronounced Mehtuh-bye-cal), was about to receive its coveted Food and Drug Administration (FDA) approval

Metabical Case Study

2215 words - 9 pages Metabical: Pricing, Packaging, and Demand Forecasting 1. Evaluate the pros and cons of Barbara’s forecasting methods. Which one would you use and what is your demand forecast for the next five years? Barbara was confident that sales of Metabical would quickly take off once health care providers and overweight individuals understood that value proposition of the new drug. Barbara has the experience to put together a forecast of demand based

Metabical Case Solutions

1464 words - 6 pages Andrew Weeden, Jason Giest, Kerri Kuhn Group 12 Metabical Case Current Competition Metabical is the “first and only prescription weight loss drug to receive FDA approval.” This prescription drug has less side affects than current weight loss options, which creates a market niche because if people are not obese but want to lose 10-30 pounds they might consider it if the negative affects are subtle. CSP is targeting overweight people (BMI

Metabical: Positioning and Communications Strategy for a New Weight-Loss Drug

4985 words - 20 pages 4240 JULY 22, 2010 JOHN A. QUELCH HEATHER BECKHAM Metabical: Positioning and Communications Strategy for a New Weight-Loss Drug “I have tried countless diets and every new weight-loss pill that has come on the market. Nothing seems to take off those extra pounds. With diets, I am miserable because I am starving all the time, and none of the weight-loss pills seem to work. I might lose a couple pounds, but I never reach my weightloss goals

Cambridge Sciences Pharmaceuticals Case Study

1534 words - 7 pages international thought-leaders. From a key note speaker and clinical trials perspective our consultants therefore represent a valuable resource to the company. Furthermore, Bayer’s link through Irish Oncologists to these U.S. KOLs, known as “tier one KOLs”, is of significant benefit particularly when planning and organising pre-launch speaker events. Like Cambridge Sciences Pharmaceuticals’ (CSP) plans for Metabical in the pre-launch stage, especially


836 words - 4 pages Business Review, December 2010, Reprint # R1012C 25. Reference Article: “Adding Social Media to the Marketing Mix”, by Guillermo Armelini and Julian Villanueva, IESE. -- Insight Magazine, June 15, 2011, Harvard Business School product number IIR051-PDF-ENG 26. Case 4: “Metabical: Positioning and Communication Strategy for a New Weight-Loss Drug” HBS Brief Case # 4240, July 2010 Session 9 27. “The Focus Process Overview, GE

Freedom And Responsibility

2141 words - 9 pages Built within the Constitution of the United States are specifically defined freedoms that are guaranteed to all citizens. Conversely, with every constitutional freedom there comes a corresponding responsibility. On September 25, 1789, the state legislature’s twelve proposed amendments were transmitted by congress, the first two dealing with congressional representation and congressional pay. The following numbers three through twelve were

Hate Crime Laws

2348 words - 10 pages On June 7, 1998, 49-year-old James Byrd Jr. of Texas accepted a ride from three white men, who then beat him severely, urinated on him, chained him by his ankles to the back of their pick-up truck, dragged him for three miles into the countryside, and dumped his corpse in front of an African-American cemetery (Graczyk). A little over a year later, a jury sentenced ring leader John King to death by lethal injection (“Man Executed for Dragging

Rational Emotional Behavior Therapy Case Study Conceptualization And Treatment Plan

2140 words - 9 pages Rational Emotional Behavior Therapy Case Study of Sarah: A Conceptualization and Treatment Plan Rational emotive behavior therapy, REBT, was developed by Albert Ellis and holds the central belief that the events in our lives do not cause our disturbances but that they are instead caused by our view of the events (Murdock, 2009). Murdock (2009) states that “people are seen as responsible for their behavior” (p. 279) but, because they are

Holidays In Albania

1636 words - 7 pages Have you ever thought about having exciting and incredibly cheap vacations? Albania might be the right choice. According to My Travel Guide, Albania is ranked the fourth among ten places worth visiting in Eastern Europe (“Top 10 Eastern European Destinations”). One can encounter three kinds of vacations in this Mediterranean country: winter, summer, and cultural. The ideal places to spend your winter vacations are the Albanian Alps. They are

Related Essays

Metabical Essay

1001 words - 5 pages Problem statement Pricing must be decided for Metabical that captures the accurately forecasted demand of the target market. Because of heavy competition such as Alli , it is important to create a package that can be priced accurately to drive up sales and consistency of a 12 week drug. Situation Analysis Cambridge Sciences Pharmaceuticals’ (CSP) is international health care company. Their focus is on developing, manufacturing and marketing

Metabical Essay

833 words - 4 pages METABICAL CASE ANALYSIS Metabical is a prescription drug produced by Cambridge Sciences Pharmaceuticals (CSP) for weight loss, which was the first and only prescription drug to obtain FDA approval. The drug was developed to help aid people in the overweight segment to lose 10 to 30 pounds. Barbara Printup is the marketing director in charge of selecting a price for the new prescription drug. In a study CSP did with Metabical, people with a

Metabical Essay

3175 words - 13 pages Case Background Cambridge Science Pharmaceuticals (CSP) is an international health care company that develops, manufactures and markets products that treat metabolic disorders, gastrointestinal diseases, immune deficiencies and other chronic and acute medical conditions. In April of 2008, CSP’s latest product Metabical, which was a new drug that had been clinically proven to be effective at achieving weight-loss in moderately overweight

Metabical Essay 602 Words

602 words - 3 pages Do you remember… – CURRENT SOLUTIONS – ™ WEIGHT LOSS DRUGS ™ DIET PLAN ™ EXERCISE PLAN ™ WEIGHT MANAGEMENT SUPPORT PROGRAM BETTER SOLUTION – Group 7 -AJINKYA-DIVYANGANA-KETAKI-SUHAIL-TEAM- OBJECTIVES: – ™ Product benefits ™ Target customers ™ Packaging strategy ™ Forecasting demand ™ Pricing strategy ™ Profitability and ROI Metabical – only through a ™ FDA approved and can be bought prescription